Journal of the Society of Cosmetic Scientists of Korea (대한화장품학회지)

Society of Cosmetic Scientists of Korea (대한화장품학회)
권호 표지

A Research Trend of Natural Product on Well-Being Industry

웰빙산업에서의 천연물 연구 동향

  • 김기호 ((주)바이오랜드 생명공학연구소) ;
  • 고강일 ((주)바이오랜드 생명공학연구소) ;
  • 강은정 ((주)바이오랜드 생명공학연구소) ;
  • 양은경 ((주)바이오랜드 생명공학연구소) ;
  • 박수남 (서울산업대학교 정밀화학과)
  • Published : 2004.11.01
Download PDF
⟨ Previous Next ⟩

Abstract

Recently, our society has prominently raised the desire to well-being life since not only our economical situations are better than before, but environmental pollution become serious. In well-being trends, the natural or nature-related products are also issued on their usages as bio-/raw materials for our living industries, such as cosmetics, household goods, and so on. Especially, various materials which comes from medicinal plants has been discovered their physiological properties and validated their functions. Thus, they have been subjected to several processes, including extraction, isolation and concentration, and popularly introduced to cosmetic industry. In these reasons, a variety of cosmetic Products using natural materials has been developed, which are focused on whitening, wrinkle improvement, and anti-aging. In this report, we present a brief review of the function and classification of natural products interested in until now, and introduce the natural materials for cosmetics having physiological activities on skin, including Fructan, Acrea extract, Portulaca extract, Licorce extract, Dandelion extract, Ulmus extract, SC-glucan, Arbutin, and Sophora extract.

최근 생활수준의 향상과 더불어 자연친화적인 제품을 사용하고자 하는 웰빙소비성향이 두드러지며 천연소재를 이용한 각종 생활용품이나 화장품의 개발도 매우 활발하게 진행되고 있다. 특히 민간에서 오랫동안 약재로 사용해 오던 식물들의 생리활성들이 피부과학적으로 입증되면서 그 식물들로부터 유효성분을 농축하거나 분리하여 화장품 등에 이용하고 있다. 또한 기능성 화장품(functional cosmetics)의 출현으로 소비자들의 인식도 높아져 피부의 생리활성을 향상시켜주는 천연원료를 첨가하여 미백(whitening), 주름개선(wrinkle improvement) 등의 효과를 나타내는 제품들도 많이 개발되어 왔다. 본고에서는 그 동안 연구되어져 온 천연물을 기능별로 분류하여 간략히 설명하고 화장품 천연원료로 개발된 fructan, Areca extract, Portulaca extract, Licorice extract, Dandelion extract, Ulmus extract, SC-glucan, Arbutin, Sophora extract 등의 피부 생리환성 등을 소개하고자 한다.

Keywords

References

  1. M. S. Lee, Looking at 'Well-Being' in terms of lifestyle: Healthy or trendy, Korean Living Science Assoiation, 13(3), 477 (2004)
  2. 특허청 약품화학심사담당관실, 2003 신기술동향조사 보고서: 천연물 의약 및 화장품, 특허청, 대전, vol. I, II (2003)
  3. 약용 허브의 기능연구, 건강산업신문사, 도쿄, 일본, 19 (1999)
  4. K. S. Mun, Components and uses of medical plants, Ilweolseogak, Seoul, Korea, 137 (1999)
  5. 약용 허브의 기능연구, 건강산업신문사, 도쿄, 일본, 34 (1999)
  6. 약용 허브의 기능연구, 건강산업신문사, 도쿄, 일본, 122 (1999)
  7. K. S. Mun, Components and uses of medical plants, Ilweolseogak, Seoul, Korea, 508 (1999)
  8. 약용 허브의 기능연구, 건강산업신문사, 도쿄, 일본, 139 (1999)
  9. 약용 허브의 기능연구, 건강산업신문사, 도쿄, 일본, 187 (1999)
  10. K. S. Mun, Components and uses of medical plants, Ilweolseogak, Seoul, Korea, 279 (1999)
  11. 약용 천연물의 기능연구, 건강산업신문사, 도쿄, 일본, 197 (1999)
  12. K. S. Mun, Components and uses of medical plants, Ilweolseogak, Seoul, Korea, 438 (1999)
  13. G. D. Bonnett, I. M. Sims, R. J. Simpson, and A. J. Cairns, Structural diversity of fructan in relation to the taxonomy of the Poaceae, New Phytologist, 136, 11 (1997)
  14. G. A. F. Hendry and R. K. Wallace, The origin, distribution, and evolutionary significance of fructan, in Science and Technology of Fructans, M. Suzuki and N. J. Chatterton Eds., CRC Press, Boca Raton, FL. 119 (1993)
  15. E. A. H. Pilon-Smits, M. J. M. Ebskamp, M. J. Paul, M. J. W. Jeucen, P. J. Weisbeek, and S. C. M. Smeekens, Improved performance of transgenic fructan-accumulating tobacco under drought stress, Plant Physiol., 107, 125 (1995) https://doi.org/10.1104/pp.107.1.125
  16. M. J. Pabst, Levan and levansucrase of Actinomyces viscosus, Infect. Immun., 15, 518 (1977)
  17. T. N. Warner and C. H. Miller, Cell-associated levan of Actinomyces viscosus, Infect. Immun., 19, 711 (1978)
  18. K. Tanaka, T. Karigane, S. Fujii, T. Chinzaka, and S. Niagamura, Intermolecular fructosyl and levan biosyl transfers by levan fructotransferase of Arthrobacter ureafaciens, J. Biochem (Tokoyo)., 97, 1679 (1985)
  19. R. Dedonder and C. Peaud-Lenoel, Studies on the levansucrase of Bacillus subtilis. I. Production of levans and levansucrase (levan-succharotransfructo-sidase) by cultures of Bacillus subtilis, Bull. Soc. Chim. Biol. (Paris), 39, 483 (1957)
  20. A. Fuchs, Synthesis of levan by pseudomonas, Nature (London) 178, 921 (1956)
  21. R. Lesher, Levan Production by Rothia Dentocariosa And Its Biological Activity, Ph.D. Dissertation, West Virginia University, U.S.A. (1976)
  22. T. Tanaka, S. Yamamoto, S. Oi, and T. Yamamoto, Structures of heterooligosaccharides synthesized by levansucrase, J. Biochem. (Tokyo), 90, 521 (1981)
  23. 이재섭, 양은경, 이정하, 김철호, 박수남, 이종원, 김기호, Zymomonas mobilis에 의해 생성된 Fructan (Levan)의 특성 및 화장품 원료로의 개발, 대한화장품학회지, 28(1), 186 (2002)
  24. I. K. Cohen, R. F. Diegelmann, and W. J. Lindblad, Wound Healing: Biochemical and Clinical Aspects, Saunders, (1992)
  25. P. J. Dykes, M. J. Edwards, O. V. Merrett, H. E. Morgan, and R. Marks, In vitro reconstruction of human skin: The use of skin equivalents as potential indicators of cutaneous toxicity, Toxic. In Vitro, 5, 1 (1991)
  26. S. O. Kang, K. K. Lee, and J. D. Choi, Free radical scavenging activity and charcaterization of the extracts from Alpinia katsumadai and Areca catechu, J. Cosmet. Sci., 27(1), 133 (2001)
  27. K. K. Lee and J. D. Choi, Areca catechu L. extract. I. Effect on elastase and aging, J. Cosmet. Sci., 49, 285 (1998)
  28. K. S. Mun, Components and uses of medical plants, Ilweolseogak, Seoul, Korea, 227 (1999)
  29. M. Takeyoshi, S. Noda, and K. Yamasaki, Differences in responsiveness of mouse strain against p-benzoquinone as assessed by non-radioisotopic murine local lymph node assay, Exp Anim., 53(2), 171 (2004)
  30. K. S. Mun, Components and uses of medical plants, Ilweolseogak, Seoul, Korea, 438 (1999)
  31. C. H. Jeong and K. H. Shim, Tyrosinase inhibitor isolated from the leaves of Zanthoxylum piperitum, Biosci Biotechnol Biochem., 68(9), 1984 (2004)
  32. K. S. Mun, Components and uses of medical plants, Ilweolseogak, Seoul, Korea, 750 (1999)
  33. T. J. Kim, Korean resources plants. Vol. 4, Seoul National University Press, Seoul, Korea, 307 (1996)
  34. J. K. Kim, Illustrated natural drugs encyclopedia. Vol. 1, Namsundang, Seoul, Korea, 77 (1997)
  35. J. W. Jo, Encyclopedia of oriental medicine, Vol. 10, Kyeung Hee University Press, Seoul, Korea, 514 (1999)
  36. E. Racz-Kotilta, G. Racz, and A. Solomon, The action of Taraxacum officinale extracts on the body weight and diuresis of laboratory animals, Planta Med, 26, 212 (1974)
  37. C. A. Williams, F. Goldstone and J. Greenham, Flavonoids, cinnamic acids and coumarins from the different tissues and medicinal prepapations of Taraxacum officinale, Phytochemistry, 42(1), 121 (1996)
  38. S. N. Park, Protective effect of isoflavone, genistein from soybean on singlet oxygen induced photohemolysis of human erythrocytes, Korean J. Food Sci. Technol., 35, 510 (2003)
  39. K. H. Lee, E. K. Jeon, S. Y. Yoo, and M. J. Oh, Antioxidative activity of Ulmus cortex extract, Korean J. Postharvest Sci, Technol., 7(4), 373 (2000)
  40. N. D. Hong, Y. S. Rho, N. J. Kim, and J. S. Kim, Studies on the constiyuents of Ulmi cortex, Kor. J. Pharmcogn., 21(3) , 201 (1990)
  41. KR Patent 10-0407455 (2003)
  42. KR Patent 10-0445430 (2004)
  43. KR Patent 10-0328877 (2002)
  44. K. S. Mun, Components and uses of medical plants, Ilweolseogak, Seoul, Korea, 547 (1999)
  45. Arbutin: Mechanism of its depigmenting action in human melanocyte culture, The Journal of Pharmacology and Experimental Therapeutics, 276, 765 (1996)
  46. J. Yamahara, M. Mochizuki, H. Fujimura, Y. Takaishi, M. Yoshida, T. Tomimatsu, and Y. Tamai, Antiulcer action of sophora flavescens root and active constituent I, J Ethnopharmacol., 29(2), 173 (1990) https://doi.org/10.1016/0378-8741(90)90053-V
  47. D. G. Massey, Y. K. Chien, and G. Fournier-Massey, Mamane:scientific therapy for asthma, Hawaii Med J., 53(120), 350 (1994)
  48. Z. Qin, H. Den, and H. Zhuang, Effect of oxymatrine on prolonging the survival time of cardiac tissue allograft in mice and its immunologic mechanisms, Zhong Yi jie He Za Zhi., 10(2), 99 (1990)